Syndax Pharmaceuticals Inc (SNDX)
SG&A Expense Growth
48.65%
Fiscal year · Period ending:
SNDX SG&A Expense Growth
Latest reported48.65%period ending
Latest reported48.65%period ending
SNDX FY SG&A Growth (YoY) (0.00% → 48.65%)
Latest values, visible window
High-resolution chart · PNG
SNDX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 48.6462% | |
| 80.6267% | |
| 101.2208% | |
| 31.7618% | |
| 12.1573% | |
| 40.1133% | |
| -7.0862% | |
| 8.9906% | |
| 19.0676% | |
| 14.9254% | |
| 3.8899% | |
| 108.0365% | |
| 53.4917% | |
| 0.2582% | |
| 0% |